Deven is a solutions-oriented process engineer with a wide breadth of experience across the lifecycle of biologic processes from development through commercial support. At COUR, she will be responsible for process scale-up and tech transfer of advancing therapies as well as supporting manufacturing optimization efforts with an eye towards commercialization. Prior to joining COUR, Deven was a proven leader within MS&T at a fully integrated gene therapy company where she was responsible for all data management & process monitoring activities for Luxturna™, the first gene therapy product licensed for a genetic disease in the U.S.
Deven received her Bachelor of Science degree in Chemical Engineering from the University of South Carolina. She has a strong background in data analysis and has extensive experience leading cross-functional projects including process characterization, process validation, continued process verification / statistical monitoring, and technology transfer.